The industry-leading NGS variant interpretation and reporting software now includes a new Clinical Validity feature, Dynamic Candidate Disease Identification, NICE…

We are excited to announce the general availability of the Fall 2020 Release of QIAGEN Clinical Insight (QCI) Interpret. This…

A high-throughput population screening laboratory sees significant scale-up with implementation of QIAGEN Clinical Insight (QCI®) INTRODUCTION Genetic disease is the leading…

Sean Scott, QIAGEN’s Chief Business Officer and Vice President of Business Development for Clinical Genomics and Bioinformatics, discusses the N-of-One…

Introducing a novel myeloid gene panel for the GeneReader NGS System with integrated variant analysis, interpretation and reporting from QIAGEN…

We’re launching our new Sample to Insight QIAact Myeloid DNA UMI Panel! We are unveiling our new Sample to Insight…

Fall is in full swing, and 2019 is fast approaching! Here’s a look at some of the top bioinformatics-adjacent stories…

As the number of genomes sequenced each day continues to skyrocket and healthcare professionals increasingly rely on genetic information to…

The recent AMP Europe 2018 conference was a wonderful chance to catch up with old friends and establish new relationships—our…

This week is the Advances in Genome Biology & Technology annual conference, taking place this year in Orlando. The QIAGEN…

How QIAGEN Clinical Insight is leading the way for predictive and preventative care Next-generation sequencing, bolstered by powerful data analytics…

The Association for Molecular Pathology (AMP) 2016 Annual Meeting is held in Charlotte, North Carolina, from November 10-12. The theme of…